Direct-to-Consumer Telemedicine for HIV Preexposure Prophylaxis—Profit Meets Public Health
JAMA Network Open · 01.12.2025 · 8 (12) · e2546730
DOI: 10.1001/jamanetworkopen.2025.46730 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 01.12.2025. Verfasst von Douglas Krakower. Beteiligte Einrichtung: Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Zitieren
APA
Krakower, D. (2025). Direct-to-Consumer Telemedicine for HIV Preexposure Prophylaxis—Profit Meets Public Health. JAMA Network Open, 8(12), e2546730. https://doi.org/10.1001/jamanetworkopen.2025.46730
Vancouver
Krakower D. Direct-to-Consumer Telemedicine for HIV Preexposure Prophylaxis—Profit Meets Public Health. JAMA Network Open. 2025;8(12):e2546730. doi:10.1001/jamanetworkopen.2025.46730
BibTeX
@article{Krakower2025,
author = {Krakower, Douglas},
title = {Direct-to-Consumer Telemedicine for HIV Preexposure Prophylaxis—Profit Meets Public Health},
journal = {JAMA Network Open},
year = {2025},
volume = {8},
number = {12},
pages = {e2546730},
doi = {10.1001/jamanetworkopen.2025.46730}
}
EUVIMED